Medical device company Nanochon will buy $1.5 million worth of biologic company Bico’s products and services to develop the implants, according to a Dec. 9 news release. Nanochon’s joint implant technology is designed to speed up patient recovery and reduce healthcare costs.
Bico’s dispensing company, Scienion, will serve as a contract manufacturer for cartilage resurfacing implants under the deal with Nanochon. Bico is also investing $400,000 in Nanochon’s seed funding to help advance regenerative medicine technology.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
